0 Commentarii
0 Distribuiri
466 Views
0 previzualizare
Sponsor
Director
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Japan Pioneers Radiotheranostics in Geriatric Oncology CareThe global theranostics market reached USD 1.8 billion in 2022 and is projected to grow to USD 4.2 billion by 2031, exhibiting a CAGR of 11.3% during the forecast period 2024–2031, driven by rising demand for personalized and precise medical treatments. Theranostics combines diagnostics and targeted therapy to tailor care based on individual disease profiles, leveraging molecular and...0 Commentarii 0 Distribuiri 890 Views 0 previzualizare
-
Asia-Pacific Poised as Fastest-Growing CP Treatment RegionA comprehensive new analysis reveals the global Cerebral Palsy (CP) Treatment Market is expected to grow from $3.21 billion in 2022 to $4.28 billion by 2030, progressing at a compound annual growth rate (CAGR) of 3.7%. This market is evolving rapidly as innovation in regenerative medicine, neurorehabilitation, digital therapy platforms, and supportive policy initiatives gain momentum across key...0 Commentarii 0 Distribuiri 508 Views 0 previzualizare
-
Radioligand Therapy Revolution: CI Insights into the Future of Precision OncologyRadioligand therapy (RLT) combines tumor-specific ligands with radioisotopes to deliver highly targeted radiation to cancer cells with minimal impact on healthy tissues. Founded on a precision innovation model in hemophilia B, RLT is transforming the treatment of metastatic and refractory cancers. With recent clinical approvals and an expanding global pipeline, RLT promises sustained innovation...0 Commentarii 0 Distribuiri 501 Views 0 previzualizare
-
North America Leads Gene Therapy Surge with 24% CAGRGene Therapy Market Set to Expand to USD 29–55 Billion by 2033–2034 The Gene Therapy Market, valued at approximately USD 8–9 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 18–20%, reaching between USD 29 and 55 billion by 2033–34. This dynamic expansion is driven by a growing pipeline of oncology and rare disease therapies,...0 Commentarii 0 Distribuiri 623 Views 0 previzualizare
-
Home Brewing Equipment Spurs Retail BoomThe global coffee market is expected to grow from USD 269.3 billion in 2024 to USD 369.5 billion by 2030, registering a compound annual growth rate (CAGR) of 5.3%. The growth is primarily driven by a rising demand for specialty beverages, increasing home brewing, ethical sourcing practices, and robust expansion across Asia-Pacific economies. Market Overview 2024 Global Market: USD 269.3...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Price Trends & Forecast: Global Camel Meat Export Prices Rise in 2024Market Size & Forecast The camel meat market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period (2024–2031). Starting from a valuation of approximately USD 1.6 billion in 2023, the market is forecast to reach around USD 2.33 billion by 2030. This growth is driven by a combination of factors: Consumer demand for nutritious and exotic meats...0 Commentarii 0 Distribuiri 584 Views 0 previzualizare
-
Rapid Growth Ahead for Biofuel Enzymes Amid Global MandatesThe Biofuel Enzymes Market is advancing rapidly, fueled by expanding renewable fuel mandates, breakthroughs in enzyme technologies, and increased demand for sustainable energy sources. Enzymes such as cellulases, lipases, and amylases are critical biocatalysts that convert biomass into bioethanol, biodiesel, and biogas helping reduce greenhouse gas emissions and enable clean-energy access. To...0 Commentarii 0 Distribuiri 691 Views 0 previzualizare
-
Gaucher’s Disease Uncovered: CI Insights into Therapies, Pipelines, and Market TrendsGaucher’s Disease, a rare lysosomal storage disorder, is entering a new era of targeted therapies and patient-centered treatment. No longer managed solely by biweekly enzyme replacement, the field is evolving with oral agents, precision diagnostics, and the promise of gene therapy. As clinical science advances, Gaucher’s Disease is emerging as a model for rare genetic disease...0 Commentarii 0 Distribuiri 380 Views 0 previzualizare
-
U.S. Biotech Surge Fuels Exosome-Based Liquid Biopsy DevelopmentThe global exosomes market reached US$ 1.3 billion in 2023 and is projected to grow to US$ 2.7 billion by 2031, at a CAGR of 15.6% during the forecast period 2024–2031, driven by expanding applications in oncology, immunotherapy, and regenerative medicine. Exosomes small vesicles ranging from 30 to 200 nm—mediate critical intercellular signaling, including EGFR-related mechanisms...0 Commentarii 0 Distribuiri 842 Views 0 previzualizare
Sponsor
English
Arabic
עברית
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek